SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a Price

Affiliations

¹ Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada; ernesto.schiffrin@mcgill.ca.
² Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama, USA;
³ Division of General Medicine, Hypertension Section, Department of Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.

Editorial

Ernesto L Schiffrin et al. Am J Hypertens. 2016 Jan.

. 2016 Jan;29(1):2-4.

doi: 10.1093/ajh/hpv190. Epub 2015 Nov 23.

¹ Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada; ernesto.schiffrin@mcgill.ca.
² Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama, USA;
³ Division of General Medicine, Hypertension Section, Department of Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.

No abstract available

Publication types